Literature DB >> 2812242

Strategies for drug delivery through the blood-brain barrier.

W M Pardridge1.   

Abstract

Strategies for drug delivery through the blood-brain barrier include neurosurgical-based, pharmacologic-based, and physiologic-based approaches. Neurosurgical-based techniques involve the implantation of intraventricular catheters that allow for chronic drug delivery. However, this approach is limited by the much faster rates of bulk flow of CSF through the ventricular compartments as compared to the slow rates of drug diffusion down into brain parenchyma. Pharmacologic-based strategies, e.g., synthesis of lipid soluble pro-drugs, or physiologic-based strategies, e.g., the development of chimeric nutrients or chimeric peptides allow for drug delivery through the brain capillary wall, i.e., the blood-brain barrier, and allow for drug delivery directly into brain parenchyma.

Entities:  

Mesh:

Year:  1989        PMID: 2812242     DOI: 10.1016/0197-4580(89)90160-7

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  3 in total

1.  Selective contrast enhancement of individual Alzheimer's disease amyloid plaques using a polyamine and Gd-DOTA conjugated antibody fragment against fibrillar Abeta42 for magnetic resonance molecular imaging.

Authors:  Muthu Ramakrishnan; Thomas M Wengenack; Karunya K Kandimalla; Geoffry L Curran; Emily J Gilles; Marina Ramirez-Alvarado; Joseph Lin; Michael Garwood; Clifford R Jack; Joseph F Poduslo
Journal:  Pharm Res       Date:  2008-04-29       Impact factor: 4.200

Review 2.  Clinical pharmacokinetics of drugs for Alzheimer's disease.

Authors:  L Parnetti
Journal:  Clin Pharmacokinet       Date:  1995-08       Impact factor: 6.447

3.  Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma.

Authors:  Azeem Arshad; Bin Yang; Alison S Bienemann; Neil U Barua; Marcella J Wyatt; Max Woolley; Dave E Johnson; Karen J Edler; Steven S Gill
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.